Sensoria Health & Padula Rehabilitation Technologies Partner To Develop First Wearable Risk Of Fall Assessment Tool

SAN DIEGO - Oct. 25, 2022 - PRLog -- See Patient Video



Today at the American Academy of Optometry annual meeting Sensoria® Health (http://www.sensoriahealth.com) and Padula Rehabilitation Technologies (https://padularehabtech.com/) announced their collaboration to develop NeurOpTrek, the first and only truly wearable solution for Risk of Fall (ROF) assessment to monitor, prevent, and rehabilitate patients from fall injuries. Sensoria Health is the leading developer of wearable Remote Patient Monitoring and Artificial Intelligence solutions and Padula Rehabilitation Technologies is the creator of unique medical instruments for the diagnosis and rehabilitation of visual dysfunction.

Statistics show that one in four adults over the age of 65 falls and suffers an injury each year. In the U.S. alone, 37 million people seek medical treatment annually for a fall related injury at a cost of $56 billion.

According to Padula's published research studies, Visual Midline Shift Syndrome (VMSS) often affects the Center of Mass (COM) of patients, negatively impacting balance, posture, and increasing risk of fall.  The new wearable NeurOpTrek system will collect gait-related data, which will then be analyzed in near real-time in order to maximize the patient's vision potential and enable him or her to improve posture and balance through a set of custom designed yoked prism lenses to treat VMSS and other challenging conditions. With NeurOpTrek, clinicians will no longer need expensive gait systems, they only need Sensoria smart socks, the NeurOpTrek app, and a tablet.

Their mission is to develop an easy to use, patient focused, truly wearable system for the assessment and correction of visual dysfunction, affecting posture, gait, balance, and visual field loss often associated with aging or traumatic neurological accidents. For many years, Dr. William Padula lived in constant frustration due to the lack of solutions that could help his patients in the ophthalmology field of rehabilitation. He was unable to provide direct treatment options to improve patient's balance and reduce their risk of falls.

"We all wake up, take a shower and get dressed. Wouldn't it be great to be able to deliver and wear 'smart apparel' as part of our normal daily life and gather meaningful data that can help both clinicians and our patients? That idea will soon become a reality with NeurOpTrek," said Dr. Padula.  "We are very excited to work with the esteemed Dr. Padula on this challenging research and development project.  Our joint work will improve people's lives and may reduce risk of falls," said Davide Vigano, CEO and Co-founder of Sensoria Health.

NeurOpTrek is a finalist in The American Academy of Optometry Foundation (AAOF) inaugural BRIGHT IDEAS Pitch Competition, with winners to be announced at the show.